BUSINESSTECHCRUNCH
H1 secures $40M from CVS, proving SaaS startups can still attract investment
H1 has secured $40 million in funding from CVS. CEO Ariel Katz claims that while AI can replicate workflow SaaS, it cannot copy H1’s unique doctor data.
Related Signal
Adjacent reporting
- You don’t need to be an AI startup to raise. Lucra has $20M to prove it.
- RJ Scaringe has raised more than $12 billion across three startups and investors still want more
- Gitar, a startup that uses agents to secure code, emerges from stealth with $9 million
- SpaceX secures option to buy AI startup Cursor for $60bn or partner for $10bn
- Nvidia posts another record quarter, reveals $43 billion of holdings in startups
- Khosla Ventures is betting $10M on Ian Crosby, whose last startup, Bench, imploded